{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:33:18Z","timestamp":1790922798455,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["24ek0109703h0001"],"award-info":[{"award-number":["24ek0109703h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["25ek0109611h0004"],"award-info":[{"award-number":["25ek0109611h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["23bm0804028h0003"],"award-info":[{"award-number":["23bm0804028h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["24ek0109691h0001"],"award-info":[{"award-number":["24ek0109691h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["24K21430"],"award-info":[{"award-number":["24K21430"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["24K22099"],"award-info":[{"award-number":["24K22099"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.braindev.2025.104437","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:09:51Z","timestamp":1757117391000},"page":"104437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances"],"prefix":"10.1016","volume":"47","author":[{"given":"Keiko","family":"Ishigaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Taniguchi-Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2025.104437_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0387-7604(81)80002-2","article-title":"Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations","volume":"3","author":"Fukuyama","year":"1981","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104437_bb0010","series-title":"Translational Research in Muscular Dystrophy: Springer, Japan","first-page":"1","article-title":"Fukuyama congenital muscular dystrophy: clinical aspects (Chapter 1)","author":"Ishigaki","year":"2015"},{"key":"10.1016\/j.braindev.2025.104437_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng1193-283","article-title":"Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33","volume":"5","author":"Toda","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2025.104437_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/28653","article-title":"An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy","volume":"394","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2025.104437_bb0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.nmd.2018.08.001","article-title":"National registry of patients with Fukuyama congenital muscular dystrophy in Japan","volume":"28","author":"Ishigaki","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2025.104437_bb0030","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/hmg\/8.12.2303","article-title":"Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD)","volume":"8","author":"Kondo-Iida","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104437_bb0035","series-title":"Congenital muscular dystrophies","first-page":"p31","article-title":"Fukuyama type congenital muscular dystrophy","author":"Osawa","year":"1997"},{"key":"10.1016\/j.braindev.2025.104437_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ajmg.a.30978","article-title":"Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and northeast Asian populations","volume":"138","author":"Watanabe","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.braindev.2025.104437_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature10456","article-title":"Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy","volume":"478","author":"Taniguchi-Ikeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2025.104437_bb0050","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a post-translational modification with Ribitol-phosphate and its defect in muscular dystrophy","volume":"14","author":"Kanagawa","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.braindev.2025.104437_bb0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/355696a0","article-title":"Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix","volume":"355","author":"Ibraghimov-Beskrovnaya","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2025.104437_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.57.1.115","article-title":"Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy","volume":"57","author":"Hayashi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2025.104437_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JND-170255","article-title":"Muscular dystrophy with Ribitol-phosphate deficiency: a novel post-translational mechanism in Dystroglycanopathy","volume":"4","author":"Kanagawa","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.braindev.2025.104437_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajmg.1320530309","article-title":"Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy","volume":"53","author":"Yoshioka","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.braindev.2025.104437_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nmd.2008.12.005","article-title":"Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype","volume":"19","author":"Vuillaumier-Barrot","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2025.104437_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.20973","article-title":"Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness","volume":"60","author":"Murakami","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2025.104437_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nmd.2016.09.014","article-title":"The gross motor function measure is valid for Fukuyama congenital muscular dystrophy","volume":"27","author":"Sato","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2025.104437_bb0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neures.2006.08.009","article-title":"Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan","volume":"56","author":"Yamamoto","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.braindev.2025.104437_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/08830738050200041901","article-title":"Long-term prognosis of epilepsies and related seizure disorders in Fukuyama-type congenital muscular dystrophy","volume":"20","author":"Yoshioka","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104437_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.braindev.2007.05.012","article-title":"Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy","volume":"30","author":"Yoshioka","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104437_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0387-7604(01)00189-9","article-title":"Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy","volume":"23","author":"Hino","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104437_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.braindev.2015.08.010","article-title":"Respiratory management of patients with Fukuyama congenital muscular dystrophy","volume":"38","author":"Sato","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104437_bb0115","doi-asserted-by":"crossref","first-page":"e1187","DOI":"10.1542\/peds.2005-2469","article-title":"Cardiac involvement in Fukuyama-type congenital muscular dystrophy","volume":"117","author":"Nakanishi","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2025.104437_bb0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.braindev.2017.05.008","article-title":"Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy","volume":"39","author":"Yamamoto","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104437_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/pediatric15030037","article-title":"Early introduction of power mobility devices for children with Fukuyama congenital muscular dystrophy and its psychological impact on caregivers: a case report","volume":"15","author":"Fujita","year":"2023","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.braindev.2025.104437_bb0130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/hmg\/ddac286","article-title":"Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant","volume":"32","author":"Enkhjargal","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.braindev.2025.104437_bb0135","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41467-022-29473-4","article-title":"CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model","volume":"13","author":"Tokuoka","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.braindev.2025.104437_bb0140","doi-asserted-by":"crossref","first-page":"24229","DOI":"10.1038\/s41598-021-03781-z","article-title":"Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy","volume":"11","author":"Murakami","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.braindev.2025.104437_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103140","article-title":"Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy","volume":"24","author":"Taniguchi-Ikeda","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.braindev.2025.104437_bb0150","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/hmg\/ddt157","article-title":"Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression","volume":"22","author":"Kanagawa","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104437_bb0155","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/hmg\/ddy032","article-title":"Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage","volume":"27","author":"Sudo","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104437_bb0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nmd.2010.06.005","article-title":"Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea","volume":"20","author":"Lim","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2025.104437_bb0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.omtn.2023.07.011","article-title":"Branchpoints as potential targets of exon-skipping therapies for genetic disorders","volume":"33","author":"Ohara","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.braindev.2025.104437_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2025.104437_bb0175","doi-asserted-by":"crossref","first-page":"E6780","DOI":"10.1073\/pnas.1512968112","article-title":"Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program","volume":"112","author":"Morrison-Nozik","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.braindev.2025.104437_bb0180","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2353\/ajpath.2009.080709","article-title":"Inhibition of prostaglandin D synthase suppresses muscular necrosis","volume":"174","author":"Mohri","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.braindev.2025.104437_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acn3.50978","article-title":"Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy","volume":"7","author":"Komaki","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.braindev.2025.104437_bb0190","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1038\/s41598-025-91539-2","article-title":"Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy","volume":"15","author":"Ishigaki","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.braindev.2025.104437_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.braindev.2011.06.002","article-title":"Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy","volume":"34","author":"Murakami","year":"2012","journal-title":"Brain Dev"}],"updated-by":[{"DOI":"10.1016\/j.braindev.2025.104459","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:59:34Z","timestamp":1764403174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0387760425001196"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104437","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104437"}}